Viking Therapeutics Inc (VKTX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Viking Therapeutics Inc   (NASDAQ: VKTX)


Viking Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Viking Therapeutics Inc's ROI in the second quarter of 2026?
Viking Therapeutics Inc recorded a cumulative net loss of $-535 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -94.39%.

Within the Healthcare sector 617 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 3909, from total ROI ranking in the first quarter of 2026 at 4339.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -34.03 % -25.59 % -17.86 % 3.92 % 33.58 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 412 502 639 713 795
Return On Investment (TTM) -94.39 % -71.31 % -48.02 % -29.34 % -19.98 %
VKTX's Overall Ranking # 3909 # 4339 # 3599 # 3428 # 3323
Seq. Investment Change TTM -14.46 % -11.55 % -7.45 % -5.78 % -3.53 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -535 -472 -360 -237 -172

VKTX Company Profile >> Back to VKTX Roi Comparisons >> See Annual VKTX Return On Investment



Return On Investment VKTX's Ranking
Within: No.
Industry # 278
Sector # 618
Overall # 3909

Return On Investment Statistics
High Average Low
-8.09 %
-66.39 %
-487.43 %
(Sep 30 2019)   (Dec 31 2015)







Financial Statements
Viking Therapeutics Inc's II. Quarter Investments $ 412 Millions VKTX's Balance sheet
Viking Therapeutics Inc's II. Quarter Income $ -128 Millions Quarterly VKTX's Income Statement
VKTX's Income by Division See VKTX's Income by Division


VKTX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 639 880 348 145 202
Y / Y Investment Growth -27.4 % 152.65 % 139.76 % -28.02 % -17.38 %
Net Income in Millions -360 -110 -86 -69 -55
Y / Y Net Income Growth - - - - -
Annual Return On Investment -56.28 % -12.49 % -24.65 % -47.39 % -27.24 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VKTX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VKTX's Competitors
Subscribers only: Roi for Viking Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for VKTX's Customers

Other Ratios
VKTX's Roa VKTX's Inventory Turnover Ratio VKTX's Growth Rates VKTX's Dividend Statistics
VKTX's Profitability Ratios VKTX's Asset Turnover Ratio VKTX's Dividend Growth
VKTX's Roe VKTX's Valuation Ratios VKTX's Financial Strength Ratios VKTX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T22:49:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.